Drugs / Gynoflor
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT07186465 | Sep 2025 → Jun 2026 overdue | cystitis, urinary tract infection | Mahidol University | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04044599 | Mar → Jun 2020 | — | Uludag University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gynoflor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04044599 ↗ |
| Modality | Other / unclassified | “vaginal lactobacilli” NCT04044599 ↗ |